ALEXANDRIA HERNANDEZ: Open Payments
NPI 1609546696 · ELGIN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,661 in 100 payments from 18 companies in 2025. Trend: 2023 $3,255 · 2024 $2,950 · 2025 $2,661
Food & beverage: $2,661
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 13 | $552 |
| Neurocrine BioSciences, Inc. | 21 | $378 |
| ABBVIE INC. | 13 | $312 |
| Alkermes, Inc. | 6 | $275 |
| Janssen Pharmaceuticals, Inc | 7 | $204 |
| Axsome Therapeutics, Inc. | 5 | $190 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $189 |
| E.R. Squibb & Sons, L.L.C. | 3 | $148 |
| Lundbeck LLC | 11 | $139 |
| Teva Pharmaceuticals USA, Inc. | 3 | $68 |
Products named: REXULTI, INGREZZA, VRAYLAR, SPRAVATO, Auvelity, CAPLYTA, LYBALVI, COBENFY.
Industry payments across IL — which companies pay providers there.
